The filing is a routine advance notice by a venture investor; the sale may or may not be executed. Monitor subsequent Form 4 filings to confirm whether the sale was completed. No immediate read-through for the stock.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 16 $34.29entry
- T+1 · 12h ago −3.85%α −2.83% · $32.97
- T+5 · in 6d Pending
- T+20 · in 28d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Crosslink Crossover Fund VII, L.P., a director and venture investor in Chime Financial, filed a Form 144 notice of intent to sell 36,000 shares of common stock, with an approximate market value of $1.21 million based on the filing date price. The shares were originally acquired from the issuer in a private transaction in April 2016. The filing is a routine advance notice of a proposed sale by a venture fund, not an officer or executive, and represents a small fraction of the fund's disclosed holdings.
Key Facts
- Crosslink Crossover Fund VII, L.P. filed Form 144 to sell 36,000 shares of Chime Financial common stock.
- Estimated aggregate market value of the proposed sale is $1,207,213.20.
- Shares were acquired on April 19, 2016 via a private acquisition from the issuer.
- The selling entity is a director and venture capital fund, not an executive officer.
- The filing also lists multiple prior sales by Crosslink affiliates in September 2026 totaling over 1 million shares.
Financial Impact
Proposed sale of 36,000 shares valued at approximately $1.21 million, representing about 0.01% of Chime's $12.7B market cap.
Risk Factors
- The proposed sale is not guaranteed to occur; Form 144 only signals intent.
- Crosslink affiliates have been selling shares steadily since September 2026, which could indicate ongoing distribution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-011091 |
| Document: 0001950047-26-011091-index.html | 0001950047-26-011091 |
| Document: 0001950047-26-011091.txt | 0001950047-26-011091 |
Track record
39 reports on CHYM
9 of 14 bullish or bearish reports moved the stock their way by T+5. Best: +14.85% at T+5 after the Sep 14, 2026 report. 12 of 14 went positive at some point.
Filters
- Nov 17, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 17, 2026today 144 Neutral 2/10 Entry $32.97 Now $32.97 +0.00% settles Nov 25
- Nov 17, 2026today 144 Neutral 3/10 Entry $32.98 Now $32.97 −0.03% settles Nov 25
- Nov 17, 2026today 144 Neutral 2/10 Entry $32.97 Now $32.97 +0.00% settles Nov 25
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 24
- Nov 16, 20261d ago 144 Neutral 3/10 Entry $34.36 Now $32.97 −4.05% settles Nov 24
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $34.36 Now $32.97 −4.05% settles Nov 24
- Nov 13, 20264d ago SC 13G/A Neutral 3/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
- Nov 13, 20264d ago 144 Neutral 2/10 Viewing Entry $34.29 Now $32.97 −3.85% settles Nov 23
- Nov 13, 20264d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers